WHO ICTRP trial
Clinical trial of OPF-501C in patients with cancerous skin ulcers
JPRN-jRCT2051230016 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT2051230016 |
|---|---|
| Public title | Clinical trial of OPF-501C in patients with cancerous skin ulcers |
| Scientific title | Clinical trial of OPF-501C in patients with cancerous skin ulcers (Exploratory Study: Phase II)-Multicenter, open-label, uncontrolled study- |
| Primary sponsor | Kyosuke Ishii |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Cancerous Skin Ulcer |
| Interventions | Apply OPF-501C at an appropriate thickness so that the affected area (cancerous skin ulcer site to be treated) is not seen through. The investigational drug is removed after acting on the affected area according to its condition. |
| Registration date | Apr 13, 2023 |
| Target size | 12 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: